Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Clopidogrel with or without omeprazole in coronary artery disease.

Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators.

N Engl J Med. 2010 Nov 11;363(20):1909-17. doi: 10.1056/NEJMoa1007964. Epub 2010 Oct 6.

2.

Clopidogrel and PPI interaction: clinically relevant or not?

Harrison RW, Mahaffey KW.

Curr Cardiol Rep. 2012 Feb;14(1):49-58. doi: 10.1007/s11886-011-0233-y. Review.

PMID:
22090195
3.

Proton pump inhibitor and clopidogrel interaction: fact or fiction?

Laine L, Hennekens C.

Am J Gastroenterol. 2010 Jan;105(1):34-41. doi: 10.1038/ajg.2009.638. Epub 2009 Nov 10. Review.

PMID:
19904241
4.

Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.

Juhász M, Herszényi L, Tulassay Z.

Digestion. 2010;81(1):10-5. doi: 10.1159/000243717. Epub 2009 Dec 22. Review.

PMID:
20029203
5.

Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction?

Shmulevich E, Friger M, Gilutz H, Azab AN.

Can J Cardiovasc Nurs. 2011;21(4):27-36. Review.

PMID:
22165503
6.

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

Siller-Matula JM, Jilma B, Schrör K, Christ G, Huber K.

J Thromb Haemost. 2010 Dec;8(12):2624-41. doi: 10.1111/j.1538-7836.2010.04049.x. Review.

7.

Proton pump inhibitors and potential interactions with clopidogrel: an update.

Gerson LB.

Curr Gastroenterol Rep. 2013 Jun;15(6):329. doi: 10.1007/s11894-013-0329-1. Review.

PMID:
23695547
8.

Prescribing proton pump inhibitor and clopidogrel together: current state of recommendations.

Abraham NS.

Curr Opin Gastroenterol. 2011 Oct;27(6):558-64. doi: 10.1097/MOG.0b013e32834a382e. Review.

PMID:
22001826
9.

Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?

Lettino M.

Eur J Intern Med. 2010 Dec;21(6):484-9. doi: 10.1016/j.ejim.2010.08.004. Epub 2010 Sep 16. Review.

PMID:
21111931
10.

Proton pump inhibitors and clopidogrel: is it a significant drug interaction?

Oyetayo OO, Talbert RL.

Expert Opin Drug Saf. 2010 Jul;9(4):593-602. doi: 10.1517/14740331003645609. Review.

PMID:
20377472
11.

Clopidogrel and proton pump inhibitors--where do we stand in 2012?

Drepper MD, Spahr L, Frossard JL.

World J Gastroenterol. 2012 May 14;18(18):2161-71. doi: 10.3748/wjg.v18.i18.2161. Review.

12.

Drug interaction between clopidogrel and proton pump inhibitors.

Liu TJ, Jackevicius CA.

Pharmacotherapy. 2010 Mar;30(3):275-89. doi: 10.1592/phco.30.3.275. Review.

PMID:
20180611
13.

Clopidogrel with proton pump inhibitors: safe or not?

Mehta A, Mehta D, Loganathan J, Paladugu N, Bhalodkar NC.

Clin Cardiol. 2011 Sep;34(9):528-31. doi: 10.1002/clc.20928. Epub 2011 Jun 29. Review.

14.

[Dilemma between gastroprotection and cardiovascular prevention].

Venerito M, Kandulski A, Malfertheiner P.

Dtsch Med Wochenschr. 2010 Nov;135(44):2193-8. doi: 10.1055/s-0030-1267498. Epub 2010 Oct 26. Review. German.

PMID:
20979006
15.

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.

Sherwood MW, Melloni C, Jones WS, Washam JB, Hasselblad V, Dolor RJ.

J Am Heart Assoc. 2015 Oct 29;4(11). pii: e002245. doi: 10.1161/JAHA.115.002245. Review.

16.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.

Lancet. 2009 Sep 19;374(9694):989-97. doi: 10.1016/S0140-6736(09)61525-7. Epub 2009 Aug 31. Review.

PMID:
19726078
17.

The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding.

Leontiadis GI, Yuan Y, Howden CW.

Gastrointest Endosc Clin N Am. 2011 Oct;21(4):637-56. doi: 10.1016/j.giec.2011.07.005. Epub 2011 Aug 10. Review.

PMID:
21944415
18.

[Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].

Casado-Arroyo R, Muñoz-Villalenguas M, Lanas Arbeloa A.

Gastroenterol Hepatol. 2011 Aug-Sep;34(7):478-91. doi: 10.1016/j.gastrohep.2011.04.002. Epub 2011 Jun 17. Review. Spanish.

PMID:
21684042
19.

Recent safety concerns with proton pump inhibitors.

Chen J, Yuan YC, Leontiadis GI, Howden CW.

J Clin Gastroenterol. 2012 Feb;46(2):93-114. doi: 10.1097/MCG.0b013e3182333820. Review.

PMID:
22227731
20.

Management of patients with high gastrointestinal risk on antiplatelet therapy.

Cryer B.

Gastroenterol Clin North Am. 2009 Jun;38(2):289-303. doi: 10.1016/j.gtc.2009.03.005. Review.

PMID:
19446259

Supplemental Content

Support Center